South Africa should judge medicine shortages by whether patients receive their full treatment on time, not only by stock figures, according to a recent opinion piece. The author argues that public reporting on patient access would show whether current supply measures actually work. Department reassures on generics On 1 September 2026, the National Department of Health explained that changes in…
Tag: Supply Chain
-
Substandard And Falsified Medicines Threaten South Africa
South Africa’s medicines watchdog is warning that Substandard And Falsified Medicines are becoming a bigger public health risk. The South African Health Products Regulatory Authority (SAHPRA) says products bought outside formal channels can lead to treatment failure, serious harm, and even death. Weight-loss medicines have drawn attention in recent months. But SAHPRA stresses they are only one part of a…
-
Aspen Insulin Approval Advances Local Health Solutions
Aspen Pharmacare has secured a landmark regulatory win after the South African Health Products Regulatory Authority (Sahpra) approved the commercial release of Aspen’s first locally manufactured human insulin batches. The products are cleared for sale in South Africa and other African markets, moving the project from planning into live supply for patients and health systems. Aspen produces the insulin at…
-
Clicks Group Half-Year Earnings Reveal Solid Profit Growth
Clicks Group has lifted profitability at the halfway stage of its financial year, even as consumers remain under pressure. The retailer said turnover for the six months ended February rose 7.4% to R24.9bn. Headline earnings increased 6.4% to R1.5bn. Headline earnings per share (HEPS) climbed 8.1% to 653 cents. The company said share buybacks over the past 18 months helped…
-
Botswana Medicine Shortages Expose Deep Procurement Failures
Across Botswana, patients are growing used to a sentence that lands like a warning. “Ga gona molemo.” Your medication is out of stock. For mothers at clinics, elderly patients and people living with chronic illness, the phrase signals more than inconvenience. It means interrupted treatment, rising anxiety and, in some cases, worsening health. Health experts and former officials say the…
-
FDA Generic Drug Review Boosts US Drug Manufacturing
The US Food and Drug Administration (FDA) has announced the launch of a new pilot programme. This programme aims to accelerate the review process for generic drugs. Companies research, develop, and manufacture these drugs entirely within the United States. The initiative aims to incentivise pharmaceutical companies to onshore their operations. It strengthens the domestic supply chain and reduces America’s heavy…